2m 2m 2m 2m 2m 2m 2m
Xenon Pharma (XENE)
NASDAQ
$41.47-$0.63 (-1.50%)
Price as of Nov 12, 2026 8:04 AM EST- $4.1BMarket Cap
- 6.10%1-Year Change
- BiotechnologyIndustry
Xenon Pharma (XENE)
$41.47-$0.63 (-1.50%)
XENE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $42.10 | ||
Change | +$0.71 (+1.72%) | ||
Open | $41.46 | ||
High | $42.17 | ||
Low | $40.88 | ||
Previous Close | $41.39 | ||
Volume | 1,252,576 | ||
30-Day Average Volume | 1,322,277 | ||
1-Week Change | 7.43% | ||
1-Month Change | 15.53% | ||
1-Year Change | 6.10% | ||
3-Year Change | 46.03% | ||
5-Year Change | 32.85% | ||
Fundamentals | |||
Shares Outstanding | 96.8M | ||
Total Assets | $1.2B | ||
Market Cap | $4.1B | ||
Enterprise Value | $4.0B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$110.4M | ||
Free Cash Flow | -$90.6M | ||
EBIT | -$108.6M | ||
EBITDA | -$108.0M | ||
Net Working Capital | $914.8M | ||
EPS | -$1.11 | ||
Enterprise Value/EBITDA | -37 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -38 | ||
PEG | N/A | ||
Price/Free Cash Flow | -45 | ||
Price/Operating Cash Flow | -45 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue